Role of serum angiopoietin-2 level in screening for esophageal squamous cell cancer and its precursors

( views:83, downloads:0 )
Author:
ZHOU Ying-zhi()
FANG Xue-qiang()
LI Hao()
DIAO Yu-tao()
YANG Yan-fang()
ZHAO De-li()
WU Kan()
LI Hui-qing()
Journal Title:
CHINESE MEDICAL JOURNAL
Issue:
Volume 120, Issue 14, 2007
DOI:
Key Word:
angiopoietin-2;esophageal neoplasms;serum;sensitivity;diagnosis

Abstract: Background Angiopoietin-2 (Ang-2) is one of the critical regulators of tumor angiogenesis. Studies have shown a significant correlation of Ang-2 expression to tumor invasion and metastasis in various human cancers, but little is known about the serum Ang-2 (sAng-2) levels in esophageal squamous cell cancer (ESCC) and its precursors. In this study, we aimed to investigate its role in screening for ESCC and its precursors.Methods We carried out a free endoscopic screening in Feicheng City, a high ESCC incidence area in Shandong Province of China. Serum samples were collected as follows: 91 from normal subjects, 44 from patients with esophagitis,85 from patients with hyperplasia, and 13 from patients with early ESCC. In addition, 28 serum samples were obtained from patients with invasive ESCC undergoing surgery in People's Hospital of Feicheng City. All the subjects of the five groups were diagnosed by histopathology. The sAng-2 levels were tested and compared, and the diagnostic power in early or/and invasive ESCC was calculated in terms of sensitivity and other parameters.Results The sAng-2 levels were (22.0±5.5), (21.3±3.2), (20.5±3.3), (24.0±5.0), and (29.8±5.0) U/ml in normal,esophagitis, hyperplasia, early ESCC, and invasive ESCC groups respectively. It was significantly higher in early ESCC than inhyperplasia group (P=0.009). The invasive ESCC group showed the highest Ang-2 level among all groups (all P=0.000). The sensitivities of sAng-2 to early and invasive ESCC were 23.1% and 78.6% respectively.Conclusion sAng-2 level is related to carcinogenesis and progression of ESCC, but it can not be used to screen for early ESCC.

  • [1]Loges S,Clausen H,Reichelt U,Bubenheim M,Erbersdobler A,Schurr P,et al.Determination of microvessel density by quantitative real-time PCR in esophageal cancer:correlation with histologic methods,angiogenic growth factor expression,and lymph node metastasis.Clin Cancer Res 2007; 13:76-80.
  • [2]Fischer I,Gagner JP,Law M,Newcomb EW,Zagzag D.Angiogenesis in gliomas:biology and molecular pathophysiology.Brain Pathol 2005; 15:297-310.
  • [3]Chung YC,Hou YC,Chang CN,Hseu TH.Expression and prognostic significance of angiopoietin in colorectal carcinoma.J Surg Oncol 2006; 94:631-638.
  • [4]Bach F,Uddin FJ,Burke D.Angiopoietins in malignancy.Eur J Surg Oncol 2007; 33:7-15.
  • [5]Kuramoto H,Saito M,Watanabe J,Fujisawa T,Kamata Y,Nishimura Y,Arai T,et al.Angiopoietin-1,2 and Tie2 expressions in endometrial adenocarcinoma-the Ang2 dominant balance up-regulates tumor angiogenesis in the presence of VEGF.Eur J Gynaecol Oncol 2006; 27:129-134.
  • [6]Yu Q.The dynamic roles of angiopoietins in tumor angiogenesis.Future Oncol 2005; 1:475-484.
  • [7]Lee OH,Fueyo J,Xu J,Yung WK,Lemoine MG,Lang FF,et al.Sustained angiopoietin-2 expression disrupts vessel formation and inhibits glioma growth.Neoplasia 2006; 8:419-428.
  • [8]Kebebew E,Peng M,Reiff E,Duh QY,Clark OH,McMillan A.Diagnostic and prognostic value of angiogenesismodulating genes in malignant thyroid neoplasms.Surgery 2005; 138:1102-1110.
  • [9]Zhang ZL,Liu ZS,Sun Q.Expression of angiopoietins,Tie2 and vascular endothelial growth factor in angiogenesis and progression of hepatocellular carcinoma.World J Gastroenterol 2006; 12:4241-4245.
  • [10]Moon WS,Park HS,Yu KH,Jang KY,Kang MJ,Park H,et al.Expression of angiopoietin 1,2 and their common receptor Tie2 in human gastric carcinoma:implication for angiogenesis.J Korean Med Sci 2006; 21:272-278.
  • [11]Wang J,Wu K,Zhang D,Tang H,Xie H,Hong L,et al.Expressions and clinical significances of angiopoietin-1,-2 and Tie2 in human gastric cancer.Biochem Biophys Res Commun 2005; 337:386-393.
  • [12]Durkin AJ,Bloomston M,Yeatman TJ,Gilbert-Barness E,Cojita D,Rosemurgy AS,et al.Differential expression of the Tie-2 receptor and its ligands in human pancreatic tumors.J Am Coll Surg 2004; 199:724-731.
  • [13]Wang GQ,Wei WQ,Lu N,Hao CQ,Lin DM,Zhang HT,et al.Significance of screening by iodine staining of endoscopic examination in the area of high incidence of esophageal carcinoma.Chin J Cancer (Chin) 2003; 22:175-177.
  • [14]Wang GQ,Abnet CC,Shen Q,Lewin KJ,Sun XD,Roth MJ,et al.Histological precursors of oesophageal squamous cell carcinoma:results from a 13-year prospective follow-up study in a high risk population.Gut 2005; 54:187-192.
  • [15]Zhang HJ,Li JS,Li DM,Cao J,Li HM,Pang X,et al.Expression of angiopoetin-2 in human esophageal squamous cell carcinoma tissue.J Zhengzhou Univ Med Sci (Chin)2006; 41:349-351.
  • [16]Cancer Prevention and Treatment Office of the Health Ministry of China.Death investigation on malignant tumors in China.Beijing:People's Health Publishing House; 1979:334-337.
  • [17]Zhao DL,Yang YD,Chen MH,Hu MX,Zhang QH,Guo XL,et al.Study on Risk Factors of Esophageal Cancer in Feicheng City.Chin J Cancer Prev Treat (Chin) 2003; 10:27-30.
  • [18]Tew WP,Kelsen DP,Ilson DH.Targeted therapies for esophageal cancer.Oncologist 2005; 10:590-601.
  • [19]Lepage C,Bouvier AM,Manfredi S,Coatmeur O,Cheynel N,Faivre J.Trends in incidence and management of esophageal adenocarcinoma in a well-defined population.Gastroenterol Clin Biol 2005; 29:1258-1263.
  • [20]Dawsey SM,Fleischer DE,Wang GQ,Zhou B,Kidwell JA,Lu N,et al.Mucosal iodine staining improves endoscopic visualization of squamous dysplasia and squamous cell carcinoma of the esophagus in Linxian,China.Cancer 1998;83:220-231.
  • [21]Wang GQ,Liu YY,Hao CQ,Lai SQ,Wang GQ,Lu N,et al.A comparative study of endoscopic image stained by iodine and histopathology in early esophageal cancer and precancerous lesions (dysplasia).Chin J Oncol (Chin) 2004;26:342-344.
  • [22]Sun XJ,Fu H,Zheng ZH,Wang MX,Liu YH,Sun KL.Study on the correlation between expression of angiopoetin-2(Ang-2)and carcinogenesis,progression of gastric cancer.Chin J Clin Oncol (Chin) 2003; 30:536-539.
  • [23]Nakayama T,Hatachi G,Wen CY,Yoshizaki A,Yamazumi K,Niino D,et al.Expression and significance of Tie-1 and Tie-2 receptors,and angiopoietins-1,2 and 4 in colorectal adenocarcinoma:Immunohistochemical analysis and correlation with clinicopathological factors.World J Gastroenterol 2005; 11:964-969.
  • [24]Yamamoto Y,Takahashi M,Nishitani M,Kanayama HO,Kagawa S.Expression of angiopoietin-1 and -2,and its clinical significance in human bladder cancer.BJU Int 2005;95:660-663.
  • [25]Sun XD,Liu XE,Wu JM,Cai XJ,Mou YP,Li JD.Expression and significance of angiopoietin-2 in gastric cancer.World J Gastroenterol 2004; 10:1382-1385.
  • [26]Shimoyama S,Yamasaki K,Kawahara M,Kaminishi M.Increased serum angiogenin concentration in colorectal cancer is correlated with cancer progression.Clin Cancer Res 1999; 5:1125-1130.
  • [27]Freestone B,Chong AY,Lim HS,Blann A,Lip GY.Angiogenic factors in atrial fibrillation:a possible role in thrombogenesis? Ann Med 2005; 37:365-372.
  • [28]Shiojima I,Sato K,Izumiya Y,Schiekofer S,Ito M,Liao R,et al.Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure.J Clin Invest 2005; 115:2108-2118.
  • [29]Zhou YZ,Li H,Zhao DL,Li HQ.Multinomial logistic regression for the influencing factors of esophageal lesions.Chin J Public Health (Chin) 2006; 22:1437-1438.
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn